Literature DB >> 6817371

Chlorpromazine hyperalgesia antagonizes clonidine analgesia, but enhances morphine analgesia in rats tested in a hot-water tail-flick paradigm.

R M Gleeson, D M Atrens.   

Abstract

Seventy-six male Sprague-Dawley rats were tested in a hot-water (55 degrees +/- 0.5 degrees C) tail-flick paradigm. Tail-flick latencies (TFL) were obtained at 30 and 15 min before intraperitoneal injection of either morphine (2.5, 5.0 and 10.0 mg/kg) clonidine (25, 50, 100 and 200 microgram/kg), chlorpromazine (CPZ, 2.5 and 5.0 mg/kg), dual injections of these drug combinations, or a saline control injection. Further TFL measures were taken immediately following drug administration and thereafter at 15 min intervals. The mean of the pre-drug TFL's served as each rat's baseline. All other TFL's were calculated as percentage changes from that baseline. Mean changes were determined for each treatment group and differences between groups, at each test time, were analysed. Our results demonstrated morphine and clonidine analgesia but CPZ hyperalgesia. The drug interaction studies revealed that morphine analgesia is enhanced by co-administration of either clinidine or CPZ but that clonidine analgesia is antagonized by chlorpromazine. These data suggest that morphine and clonidine exert their analgesic effects through different neurochemical mechanisms. It is particularly interesting that the clonidine-CPZ combination should result in TFL's similar to baseline levels, even though both drugs are sedatives. The investigation emphasizes the value of chlorpromazine as a pharmacological tool in analgesic research because of its ability to induce hyperalgesia even though it is a sedating agent.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6817371     DOI: 10.1007/bf00432252

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

1.  Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal.

Authors:  M S Gold; D E Redmond; H D Kleber
Journal:  Am J Psychiatry       Date:  1979-01       Impact factor: 18.112

2.  Potentiation and reduction of the analgesia of morphine in the rat by pargyline.

Authors:  S Y Yeh; C L Mitchell
Journal:  J Pharmacol Exp Ther       Date:  1971-12       Impact factor: 4.030

3.  Opiates and specific receptor binding of [3H]clonidine.

Authors:  K Golembiowska-Nikitin; A Pilc; J Vetulani
Journal:  J Pharm Pharmacol       Date:  1980-01       Impact factor: 3.765

Review 4.  The design and analysis of experiments for the assessment of drug interactions.

Authors:  C L Mitchell
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

5.  Nociception is enhanced after low doses and reduced after high doses of the serotonin receptor agonist 5-methoxy-N,N-dimethyltryptamine.

Authors:  O G Berge; K Hole; H Dahle
Journal:  Neurosci Lett       Date:  1980-09       Impact factor: 3.046

6.  The periaqueductal gray: site of morphine analgesia and tolerance as shown by 2-way cross tolerance between systemic and intracerebral injections.

Authors:  Y F Jacquet; A Lajtha
Journal:  Brain Res       Date:  1976-02-27       Impact factor: 3.252

7.  Presynaptic noradrenergic alpha-receptors and modulation of 3H-noradrenaline release from rat brain synaptosomes.

Authors:  C D De Langen; F Hogenboom; A H Mulder
Journal:  Eur J Pharmacol       Date:  1979-11-23       Impact factor: 4.432

8.  Interaction of opiate peptide and noradrenalin systems: light microscopic studies.

Authors:  S J Watson; C W Richard; R D Ciaranello; J D Barchas
Journal:  Peptides       Date:  1980       Impact factor: 3.750

9.  A comparison of muscarinic cholinergic involvement in the antinociceptive effects of morphine and clonidine in the mouse.

Authors:  J J Lipman; P S Spencer
Journal:  Eur J Pharmacol       Date:  1980-06-27       Impact factor: 4.432

10.  Pain reduction by focal electrical stimulation of the brain: an anatomical and behavioral analysis.

Authors:  D J Mayer; J C Liebeskind
Journal:  Brain Res       Date:  1974-03-15       Impact factor: 3.252

View more
  6 in total

1.  Environment-specific tolerance to nicotine.

Authors:  L H Epstein; A R Caggiula; R Stiller
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Acute stress or corticosterone administration reduces responsiveness to nicotine: implications for a mechanism of conditioned tolerance.

Authors:  A R Caggiula; L H Epstein; S M Antelman; S Saylor; S Knopf; K A Perkins; R Stiller
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Different methods of assessing nicotine-induced antinociception may engage different neural mechanisms.

Authors:  A R Caggiula; L H Epstein; K A Perkins; S Saylor
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 4.  The role of antipsychotics in the management of fibromyalgia.

Authors:  Elena P Calandre; Fernando Rico-Villademoros
Journal:  CNS Drugs       Date:  2012-02-01       Impact factor: 5.749

5.  Prior stress attenuates the analgesic response but sensitizes the corticosterone and cortical dopamine responses to stress 10 days later.

Authors:  A R Caggiula; S M Antelman; E Aul; S Knopf; D J Edwards
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Influence of housing conditions and state of partner on conditioning and extinction of taste aversion to lithium and chlorpromazine.

Authors:  V Giardini
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.